Skip to content

Effect of Caffeine on Ocular Circulation in High Myopes

Effect of Caffeine on Ocular Circulation in High Myopes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03294967
Enrollment
18
Registered
2017-09-27
Start date
2017-09-01
Completion date
2019-12-31
Last updated
2020-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Choroid, High Myopia

Keywords

High Myopia, Caffeine, Choroidal Thickness, Choroidal Volume, Optical Coherence Tomography, Optical Coherence Tomography Angiography

Brief summary

To investigate the effect of caffeine on ocular circulation by using Optical Coherence Tomography and Optical Coherence Tomography Angiography. This study will evaluate blood supply to the inner and outer retina after consumption of 200mg caffeine capsule, in particular its effect in high myopes.

Detailed description

Caffeine could cause vasoconstriction. Previous studies revealed a reduction of retinal blood vessels diameter, a decrease in macular blood flow, and a decrease in blood velocity of optic nerve. Research devices, such as laser speckle tissue circulation analyzer and blue field simulation technique, were used in previous studies. With an advancement of technology such as optical coherence tomography (OCT), choroidal thickness can be measured, which indicates blood supply to outer retina. In addition, superficial retinal vasculature can be measured using optical coherence tomography angiography (OCTA). Previous studies found that subfoveal choroidal thickness declined with increase in myopia. A negative association between subfoveal choroidal thickness and axial length was also found. A recent study found a negative association between retinal vessel density with axial length in Chinese myopes using OCTA. Therefore, caffeine consumption may further make high myopes prone to ocular diseases development due to poor ocular circulation. The current study will use OCTA to measure the superficial retinal vasculature and OCT to measure choroidal thickness and choroidal volume of high myopes after consumption of caffeine capsule. Statistical analysis Normality of data will be assessed. The effect of caffeine on choroidal thickness, choroidal volume, vessel density, and perfusion density of superficial retinal layers will be analysed using repeated-measures ANOVA (co-variates) to compare baseline data and that after caffeine consumption at various time points. If significant difference is obtained, post hoc tests will be conducted to compare results from various time points with the baseline data. Difference between different age groups will be compared using unpaired t-test or Mann Whitney test, as appropriate.

Interventions

DIETARY_SUPPLEMENTCaffeine

As in group descriptions

DIETARY_SUPPLEMENTVitamin E

As in group descriptions

Sponsors

The Hong Kong Polytechnic University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Subject)

Masking description

Participants will not see the label of the capsule.

Intervention model description

This will be a crossover study. Each subject is required to consume 200mg caffeine capsule and 200IU vitamin E control capsule, as control, in two different visits. The two visits will be randomized, with a washout period of at least one week.

Eligibility

Sex/Gender
ALL
Age
20 Years to 49 Years
Healthy volunteers
Yes

Inclusion criteria

* Refractive error should be at least -6 Diopters or lower (spherical equivalent) * Best corrected visual acuity of at least 6/6 * Non-smoker

Exclusion criteria

\- Diagnosed with any ocular diseases and systemic diseases

Design outcomes

Primary

MeasureTime frameDescription
Choroidal thicknessWithin 4 hoursChoroidal thickness measured by the optical coherence tomography

Secondary

MeasureTime frameDescription
Retinal vessel densityWithin 4 hoursSuperficial retinal vessel density measured by OCTA

Countries

Hong Kong

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026